Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06363461 · ClinicalTrials.gov registry record · Phase 2
Study of TDM-180935 in Atopic Dermatitis Patients
A Phase 2 study, sponsored by Technoderma Medicines.
- Completed
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
NCT06363461 is a Phase 2 study that has completed, run by Technoderma Medicines. The registered enrollment target is 24 participants.
The verdict
NCT06363461, a Phase 2 study, has completed, sponsored by Technoderma Medicines.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
Study Summary
Randomized, Vehicle-controlled, Parallel Group Study of TDM-180935 in Atopic Dermatitis Patients
Interventions
- DRUG TDM-180935 topical ointment 1.0%
- DRUG TDM-180935 topical ointment 2.0%
- DRUG TDM-180935 topical vehicle ointment 1
- DRUG TDM-180935 topical vehicle ointment 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2024-04-13 |
| Est. Completion | 2025-04-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06363461
The ClinicalTrials.gov registry entry for NCT06363461 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Technoderma Medicines, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which TDM-180935 topical ointment 1.0% is the first listed.
NCT06363461 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06363461 about?
NCT06363461 is a clinical study titled "Study of TDM-180935 in Atopic Dermatitis Patients". Randomized, Vehicle-controlled, Parallel Group Study of TDM-180935 in Atopic Dermatitis Patients
What is the current status of trial NCT06363461?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2024-04-13. Estimated completion is 2025-04-08.
What interventions are being tested in trial NCT06363461?
The interventions under investigation include: TDM-180935 topical ointment 1.0% (DRUG), TDM-180935 topical ointment 2.0% (DRUG), TDM-180935 topical vehicle ointment 1 (DRUG), TDM-180935 topical vehicle ointment 2 (DRUG).
Who is sponsoring clinical trial NCT06363461?
This trial is sponsored by Technoderma Medicines, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.